Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib

Detalles Bibliográficos
Autores principales: Gower, Arjan, Golestany, Barry, Gong, Jun, Singhi, Aatur D., Hendifar, Andrew Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446504/
https://www.ncbi.nlm.nih.gov/pubmed/32923899
http://dx.doi.org/10.1200/PO.19.00365
_version_ 1783574151112425472
author Gower, Arjan
Golestany, Barry
Gong, Jun
Singhi, Aatur D.
Hendifar, Andrew Eugene
author_facet Gower, Arjan
Golestany, Barry
Gong, Jun
Singhi, Aatur D.
Hendifar, Andrew Eugene
author_sort Gower, Arjan
collection PubMed
description
format Online
Article
Text
id pubmed-7446504
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74465042020-09-30 Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib Gower, Arjan Golestany, Barry Gong, Jun Singhi, Aatur D. Hendifar, Andrew Eugene JCO Precis Oncol Case Reports American Society of Clinical Oncology 2020-07-27 /pmc/articles/PMC7446504/ /pubmed/32923899 http://dx.doi.org/10.1200/PO.19.00365 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Reports
Gower, Arjan
Golestany, Barry
Gong, Jun
Singhi, Aatur D.
Hendifar, Andrew Eugene
Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
title Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
title_full Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
title_fullStr Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
title_full_unstemmed Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
title_short Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib
title_sort novel alk fusion, ppfibp1-alk, in pancreatic ductal adenocarcinoma responsive to alectinib and lorlatinib
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446504/
https://www.ncbi.nlm.nih.gov/pubmed/32923899
http://dx.doi.org/10.1200/PO.19.00365
work_keys_str_mv AT gowerarjan novelalkfusionppfibp1alkinpancreaticductaladenocarcinomaresponsivetoalectinibandlorlatinib
AT golestanybarry novelalkfusionppfibp1alkinpancreaticductaladenocarcinomaresponsivetoalectinibandlorlatinib
AT gongjun novelalkfusionppfibp1alkinpancreaticductaladenocarcinomaresponsivetoalectinibandlorlatinib
AT singhiaaturd novelalkfusionppfibp1alkinpancreaticductaladenocarcinomaresponsivetoalectinibandlorlatinib
AT hendifarandreweugene novelalkfusionppfibp1alkinpancreaticductaladenocarcinomaresponsivetoalectinibandlorlatinib

Ejemplares similares